Impact of Biologic Treatment of Crohn's Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland
Background: There is conflicting evidence on the impact of biologic treatment on the rate of complications and surgeries in Crohn's disease (CD). We aimed to assess real-world consequences of biologic treatment of CD.Methods: All adult patients with CD treated with infliximab and adalimumab in...
Saved in:
Main Authors: | Przemysław Holko (Author), Paweł Kawalec (Author), Andrzej Pilc (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
by: Krzysztof Piotr Malinowski, et al.
Published: (2018) -
Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries
by: Ewa Stawowczyk, et al.
Published: (2019) -
Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis
by: Kinga Krawczyk, et al.
Published: (2023) -
Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review
by: Paweł Kawalec, et al.
Published: (2017) -
Resources and activities of voivodeship occupational medicine centers in Poland during the COVID-19 pandemic
by: Andrzej Marcinkiewicz, et al.
Published: (2024)